Cognition and anxiety: the cognitive effects of anti-anxiety medication

被引:19
作者
Hindmarch, I [1 ]
机构
[1] Milford Hosp, Human Psychopharmacol Res Unit, Godalming GU7 IUF, Surrey, England
关键词
generalized anxiety disorder; cognition; benzodiazepines; hydroxyzine;
D O I
10.1111/j.1600-0447.1998.tb05972.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
There does not appear to be a single hypothesis or theory which can adequately explain the aetiology of anxiety, although there is no shortage of contenders. Neurochemical, existential, sociogenic, familial, pathological, psychodynamic and behavioural explanations have all been offered as putative reasons for the psychological disorder, which in its various representations (panic disorder, obsessive-compulsive disorder, phobias, post-traumatic stress disorder, generalized anxiety disorders, etc.) can affect up to 20% of the population on a lifetime basis (1). Notwithstanding the variety of theories and the diversity of presentation of anxiety disorders, it would appear that cognitive dysfunction of one sort or another is a characteristic feature of anxiety in all its manifestations. Indeed, it is possible to argue that a cognitive impairment is the primary presenting feature of pathological anxiety, with the characteristic syndrome of somatic symptoms as secondary or necessary consequences of such cognitive disorder.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 55 条
[1]   ACUTE EFFECTS OF HYDROXYZINE ON NOCTURNAL SLEEP AND SLEEP TENDENCY THE FOLLOWING DAY - A C-EEG STUDY [J].
ALFORD, C ;
ROMBAUT, N ;
JONES, J ;
FOLEY, S ;
IDZIKOWSKI, C ;
HINDMARCH, I .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1992, 7 (01) :25-35
[2]   PHARMACODYNAMIC EFFECTS OF BUSPIRONE AND CLOBAZAM [J].
ALFORD, C ;
BHATTI, JZ ;
CURRAN, S ;
MCKAY, G ;
HINDMARCH, I .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (01) :91-97
[3]  
Beck A. T., 1985, ANXIETY DISORDERS PH
[4]  
BLACK DW, 1993, ARCH GEN PSYCHIAT, V50, P44
[5]  
BRESLOW IH, 1968, CURR THER RES CLIN E, V10, P421
[6]  
Brunswik Egon., 1956, Perception and the Representative Design of Psychological Experiments
[7]  
BUHLER RA, 1955, PSYCH ABSTR, V39, P701
[8]   THE USE OF ANTI-DEPRESSANTS AND BENZODIAZEPINES IN THE PERPETRATORS AND VICTIMS OF ACCIDENTS [J].
CURRIE, D ;
HASHEMI, K ;
FOTHERGILL, J ;
FINDLAY, A ;
HARRIS, A ;
HINDMARCH, I .
OCCUPATIONAL MEDICINE-OXFORD, 1995, 45 (06) :323-325
[9]  
DEBRABANDER A, 1991, REV FRANCAISE PSYCHI, V1, P2
[10]  
DEFIGUEREDO R, 1981, R SOC MED S SERIES, V43, P175